Lidia S. Foteeva

Preclinical characterization of anticancer gallium(III) complexes: Solubility, stability, lipophilicity and binding to serum proteins

Alexander V. Rudnev, Lidia S. Foteeva, Christian R. Kowol et al. · Journal of Inorganic Biochemistry · 2006 · 109 citations

Medicinal Chemistry, Biochemistry, Medicine +7

Application of capillary electrophoresis–inductively coupled plasma mass spectrometry to comparative studying of the reactivity of antitumor ruthenium(III) complexes differing in the nature of counter-ion toward human serum proteins

Jan K. Abramski, Julia Ferenc, Lidia S. Foteeva et al. · Journal of Chromatography A · 2008 · 49 citations

Human Serum Proteins, Medicinal Chemistry, Biochemistry +14

Probing the stability of serum protein–ruthenium(III) drug adducts in the presence of extracellular reductants using CE

Andrei R. Timerbaev, Lidia S. Foteeva, Alexander V. Rudnev et al. · Electrophoresis · 2007 · 46 citations

Pharmaceutical Science, Chemoprevention Strategy, Extracellular Reductants +21

Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(iii) drug bound to holo-transferrin in simulated cancer cytosol

Svetlana S. Aleksenko, Magdalena Matczuk, Xifeng Lu et al. · Metallomics · 2013 · 40 citations

Engineering, Redox Biology, Ruthenium Ion +21

Enhancing the Cytotoxic Activity of Anticancer Pt^IV Complexes by Introduction of Lonidamine as an Axial Ligand

Yulia N. Nosova, Lidia S. Foteeva, Timur I. Fetisov et al. · European Journal of Inorganic Chemistry · 2016 · 38 citations

Pt Iv Complexes, Log P, Cytotoxic Activity +17